Salomon & Ludwin’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.1K | Buy |
1,598
+183
| +13% | +$8.72K | 0.01% | 215 |
|
|
2025
Q1 | $86.3K | Hold |
1,415
| – | – | 0.01% | 189 |
|
|
2024
Q4 | $80K | Sell |
1,415
-428
| -23% | -$24.2K | 0.01% | 197 |
|
|
2024
Q3 | $95.4K | Buy |
1,843
+249
| +16% | +$12.9K | 0.01% | 196 |
|
|
2024
Q2 | $66.2K | Sell |
1,594
-936
| -37% | -$38.9K | 0.01% | 231 |
|
|
2024
Q1 | $137K | Buy |
2,530
+523
| +26% | +$28.4K | 0.01% | 217 |
|
|
2023
Q4 | $116K | Hold |
2,007
| – | – | 0.01% | 210 |
|
|
2023
Q3 | $116K | Buy |
+2,007
| New | +$116K | 0.01% | 210 |
|
|
2023
Q2 | – | Sell |
-3,083
| Closed | -$214K | – | 173 |
|
|
2023
Q1 | $214K | Hold |
3,083
| – | – | 0.03% | 159 |
|
|
2022
Q4 | $222K | Buy |
+3,083
| New | +$222K | 0.03% | 156 |
|
|
2020
Q2 | – | Sell |
-459
| Closed | -$26K | – | 80 |
|
|
2020
Q1 | $26K | Sell |
459
-515
| -53% | -$29.2K | 0.01% | 125 |
|
|
2019
Q4 | $63K | Buy |
974
+540
| +124% | +$34.9K | 0.01% | 97 |
|
|
2019
Q3 | $22K | Hold |
434
| – | – | ﹤0.01% | 135 |
|
|
2019
Q2 | $20K | Hold |
434
| – | – | ﹤0.01% | 124 |
|
|
2019
Q1 | $21K | Hold |
434
| – | – | ﹤0.01% | 123 |
|
|
2018
Q4 | $23K | Buy |
+434
| New | +$23K | 0.01% | 117 |
|